Altium Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Altium Wealth Management's XBI Position: Q2 2018 in Review
Altium Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 3,190 shares — an estimated $280K sold.
Altium Wealth Management first reported a position in XBI in Q4 2017 and held it in 2 quarters. The position peaked at $280K in Q1 2018. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.
- Altium Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
- Altium Wealth Management sold 3,190 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $280K.
- Altium Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 2 quarters.
- Altium Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $280K in Q1 2018.
- 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.
Based on Altium Wealth Management's 13F filing for Q2 2018, filed 14 Aug 2018.